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The London fog incident in 1952 demon-
strated that air pollution is associated with an
abrupt increase in mortality (1). Although lev-
els of air pollution have been greatly reduced
since the 1950s, it has been estimated that as
many as 60,000 deaths each year in the
United States are related to air pollution (2,3).
Among the components of air pollution, ﬁne
particles, which have a mass median aerody-
namic diameter less than 10 µm (PM10) and
are emitted mainly from the combustion of
fossil fuels, have been shown epidemiologi-
cally to be associated with mortality (4). PM10
may be deleterious because it consists of a
mixture of toxic compounds such as soot, acid
condensates, and sulfate and nitrate particles,
and because of its small diameter, allowing for
inhaled PM10 to penetrate deeply into the
lung (5). Increased levels of air pollution are
associated with death not only from lung
cancer but also from cardiopulmonary disease
(4). The inﬂuence of air pollution on cardio-
vascular diseases is of growing concern.
Increased mortality attributed to air pollution
could be caused by particulate matter alone
or, more likely, in combination with other
pollutants such as carbon monoxide (CO) or
nitrogen dioxide (NO2). Air pollution that
was monitored in Phoenix, Arizona, from
1995 to 1997comprised a mixture of PM10,
particles with a mass median aerodynamic
diameter less than 2.5 µm (PM2.5), and CO,
NO2, sulfur dioxide (SO2), and ozone (O3)
and was found to be associated with increased
cardiovascular mortality (6). Cardiovascular
morbidity is also affected by air pollution, as
demonstrated by Linn et al. (7) in the Los
Angeles, California, area from 1992 to 1995
where PM10, CO, and NO2 were found to
have a signiﬁcant association with cardiovas-
cular hospitalizations. Schwartz (8) reported
that daily variations of PM10 and CO were
linked to daily hospital admissions among the
elderly. Knöbel et al. (9) showed that the rate
of sudden infant death syndrome increased
with elevated levels of air pollution. More
direct evidence of a relationship between fatal
cardiac arrhythmia and air pollution was pre-
sented recently by Peters et al. (10). They sur-
veyed episodes of deﬁbrillation by implanted
cardioverter deﬁbrillators as related to daily air
pollution in the Boston, Massachusetts, area.
They found that frequency of deﬁbrillator dis-
charges showed a signiﬁcant correlation with
increased levels of NO2 and black carbon, and
to a lesser extent with CO and PM10, suggest-
ing that air pollution is a risk factor for cardio-
vascular diseases and for arrhythmic events in
particular (10). In that study cardiac arrhyth-
mias often occurred 2 days after incidences of
increased air pollution. Watkinson et al. (11)
used an animal model of pulmonary hyperten-
sion to demonstrate that the incidence and
duration of cardiac arrhythmias were
increased by raising the dose of inhaled small
particles in pulmonary hypertensive rats but
not in normal rats. The above observations
suggest that the effect of air pollution on the
cardiovascular system depends to a major
extent on the condition of ventricular
myocardium (myocardial substrate), i.e., the
presence of underlying heart disease predis-
poses animals to air pollution–related changes
in the cardiovascular system. 
The mechanisms by which air pollution
affects the cardiovascular system are
unknown, although several possible mecha-
nisms have been suggested including the
neural mechanisms related to the response of
the autonomic nervous system through direct
reflexes from airways or through inflamma-
tory response; the chemical effect on ion
channel function in the myocardial cell;
ischemic response in the myocardium; and
the inflammatory response that triggers
endothelial dysfunction, atherosclerosis, and
thrombosis. 
It is worth emphasizing that cardiovascular
responses to air pollution do not occur in iso-
lation from other systems, which seems to
contribute to this response. Most current
studies are designed to simultaneously study
parameters describing cardiac response [such
as electrocardiogram (ECG) signals], lung
function, immunologic response, or specific
blood variables. Such a comprehensive
approach can provide insight into overall
mechanisms underlying biologic effects of air
pollution on the human body. 
Epidemiologic evidence indicates that air pollution adversely affects the cardiovascular system,
leading to increased cardiovascular morbidity and mortality. However, the mechanisms of such an
association are unknown. Although potential mechanisms of deleterious effects of air pollution may
involve response of the respiratory system, immunologic response, or coagulation abnormalities,
the cardiovascular system seems to be the common end point of these pathways. Cardiovascular
response to any stress (which may include air pollution) is a consequence of a complex interplay
between the autonomic nervous system governing centrally mediated control of the cardiovascular
system, a myocardial substrate (current state of the myocardium) altered in the course of disease
processes, and myocardial vulnerability leading to arrhythmogenic or ischemic response. Through
the use of standard electrocardiograms (ECGs), exercise ECG testing, and long-term ambulatory
ECG monitoring, modern electrocardiology makes a valuable contribution to understanding the
different mechanistic factors involved in the increase in adverse cardiovascular events due to air
pollution. Heart rate variability analysis can provide quantitative insight into the autonomic response
of the cardiovascular system to air pollution. Analysis of ventricular repolarization in an ECG (both
duration and morphology) gives valuable information about the status and dynamic behavior of
myocardium, reﬂecting myocardial substrate and vulnerability. ST-segment analysis of ECGs is used
routinely to monitor the magnitude of ischemia and could be used to monitor subtle changes in the
myocardium in subjects exposed to air pollution. Comprehensive analysis of ECG parameters
describing the inﬂuence of the autonomic nervous system, the role of myocardial substrate, and the
contribution of myocardial vulnerability could and should be employed in air pollution studies,
especially as those mechanistic components have been proven to contribute to increased
cardiovascular morbidity and mortality in general. Key words: air pollution, cardiac death,
cardiovascular morbidity, ECG, electrocardiogram, heart rate variability, particulate matter,
repolarization. — Environ Health Perspect 109(suppl 4):533–538 (2001).
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Pathomechanisms of
Cardiac Death
Although the inﬂuence of air pollution on the
cardiovascular system is being identified in
epidemiologic studies, the pathophysiologic
mechanism underlying this association is not
known. Cardiac death is a consequence of a
complex interplay between the autonomic
nervous system governing centrally mediated
control of the cardiovascular system, a
myocardial substrate (current state of the
myocardium) altered in the course of disease
processes, and myocardial vulnerability lead-
ing to arrhythmogenic or ischemic response
(Figure 1). The presence of a single such con-
dition is usually not sufficient to trigger
death. For example, sympathetic activation in
a subject with a healthy heart is not likely to
lead to life-threatening arrhythmias. Usually a
biologic or psychologic stress induces a
cascade of events by increasing sympathetic
activation, which may alter the myocardial
substrate and subsequently increase myocar-
dial vulnerability, leading to ventricular
tachyarrhythmias, aggravation of ischemia, or
heart failure and death. Air pollution may be
a stressor sufficient to trigger this chain of
events, especially in vulnerable subjects such
as the elderly, patients with heart failure, or
those with chronic obstructive pulmonary
disease (COPD). Noninvasive electrocardiol-
ogy provides an opportunity to measure and
monitor ECG parameters reflecting the key
components of the “cardiac death triangle.”
Several of these parameters have been used to
identify high-risk individuals in studies
focused on risk stratiﬁcation of patients after
myocardial infarction, those with cardiomy-
opathy or hypertension (12). Monitoring
these ECG parameters might identify cardio-
vascular factors contributing to increased risk
of cardiac death in response to air pollution. 
The cardiovascular mechanisms leading to
cardiac death, sudden cardiac death, and
increased cardiovascular morbidity are very
similar. ECG parameters described below pro-
vide comprehensive information about the
mechanisms underlying increased risk of car-
diovascular morbidity and mortality. Cardiac
arrhythmias, especially atrial fibrillation and
supraventricular arrhythmias, are the leading
cause of hospital admissions for cardiovascular
causes in the United States and they frequently
are clinical manifestation of underlying cardio-
vascular disorders including ischemic heart dis-
ease and congestive heart failure. ECG
parameters describing myocardial damage
(abnormal QRS complex or T-wave morphol-
ogy) or myocardial ischemia (ST–T-wave
changes) give information about the presence
and the magnitude of myocardial involvement
underlying increased risk of cardiovascular
morbidity and mortality. Monitoring these
parameters in conditions of spontaneous
(ambient) or experimental air pollution in
high-risk patients is likely to elucidate mecha-
nisms by which air pollution may affect the
cardiovascular system. 
Physiologic and Methodologic
Aspects of Heart Rate
Variability
The concept that air pollution–related
increases in cardiac mortality and morbidity
may operate through changes in autonomic
control of the heart leads to recent interest in
studies employing heart rate variability
(HRV) analysis (13,14). Heart rate and the
entire cardiovascular system remain under the
constant influence of both sympathetic and
parasympathetic innervation from the auto-
nomic nervous system. Parasympathetic effect
is conveyed through vagal nerves originating
in the central nervous system (dorsal motor
nucleus and nucleus ambiguus) and innervat-
ing sinus node, atrio-ventricular node, atrial
and likely also the ventricular myocardium.
Sympathetic nerves originate in the upper
thoracic region of the spinal cord and post-
ganglionic ﬁbers innervate the sinus node, the
atrio-ventricular node, and the atrial and
ventricular myocardium. An increase in
parasympathetic activity slows the heart rate,
whereas an increase in sympathetic activity
increases the heart rate by directly affecting
the sinus node. Both vagal and sympathetic
fibers may carry afferent impulses from the
heart to the brain, triggering a feedback
response from the autonomic nervous system.
The intrinsic heart rate, governed by
electrical function of the sinus node in the
heart, is 100–120 beats per minute. However,
the parasympathetic system has profound
influence on the sinus node and overdomi-
nates the inﬂuence of the sympathetic system,
which contributes to normal resting heart
rates of 55–70 beats per minute. In cases of
stress (such as exercise), there is an increase in
sympathetic discharges from the autonomic
nervous system, which leading to an increased
heart rate. Various cardiac conditions (e.g.,
myocardial infarction, hypertension) and
noncardiac disorders (e.g., diabetes, COPD)
are associated with altered autonomic func-
tion of the cardiovascular system caused by
increased sympathetic activation, withdrawal
of parasympathetic tone, or both. 
Heart rate provides indirect insight into
constant interplay between the sympathetic
and parasympathetic systems and therefore
monitoring changes in heart rate (i.e., heart
rate variability) is useful in determining the
effect of the autonomic system on the heart
(12–15). Frequent changes in heart rate occur
in response to respiration (12–15 cycles per
minute depending on respiratory rate); other
changes in heart rate are of slower periodicity
and may occur in cycles of 1 every 10 sec up
to 1 every few minutes. Heart rate is mea-
sured by ECG using the duration of the RR
interval (i.e., the interval between R peaks of
two consecutive QRS complexes representing
heart beats), and beat-to-beat variations in the
RR interval duration reflect changes in the
autonomic nervous activity. Because the
analysis of the RR interval variation includes
only so-called normal beats, i.e., beats origi-
nating in the sinus node (atrial and ventricu-
lar ectopic beats are excluded), the term NN
intervals (normal-to-normal beat intervals) is
used to emphasize this aspect of the tech-
nique. Variation in the NN interval duration
can be measured using several methods;
time-domain statistical measures of variabil-
ity and frequency-domain analysis of the
power spectrum of the heart rate are the
most popular approaches. As indicated
above, a prolonged ECG recording (at least
5–10 min but usually 24 hr) is needed to
obtain full insight into the periodicity of
heart rate changes. The standard 12-lead
ECG with 10-sec recording is too short and
cannot be used to determine HRV. Instead,
long-term Holter recordings became the
standard method to obtain information
about beat-to-beat changes in heart rate.
Figure 1. Factors contributing to cardiac morbidity and
mortality. Speciﬁc ECG parameters reﬂecting those fac-
tors are listed in Table 1.
Autonomic
nervous system
Cardiovascular
morbidity and
mortality
Myocardial
substrate
Myocardial
vulnerability
Table 1. Noninvasive ECG parameters describing biologic
phenomena contributing to increased risk of cardiac
death.
Autonomic nervous system
Heart rate variability
Time-domain (SDNN, rMSSD, pNN50, SDANN, SDNNIX)
Frequency-domain (TP, ULF, VLF, LF, HF, LF/HF ratio)
Myocardial substrate
Left ventricular hypertrophy (QRS voltage, QRS product) 
QRS duration and morphology (conduction 
disturbances, pathologic Q waves) 
Late potentials 
QT interval duration 
QT dispersion
Principal component analysis of T wave
Exercise-induced ST-segment changes
Myocardial vulnerability
Frequency and complexity of ventricular arrhythmias
ST-segment changes
QT–RR relationship
QT- and T-wave variability 
T-wave alternansAir pollution and electrocardiogram
Time-Domain HRV Analysis
The time-domain HRV approach is based on
statistical analyses of the NN interval varia-
tion (12–14). Classical parameters are
SDNN (standard deviation of normal-to-
normal sinus beat intervals); rRMSSD (root
mean square of successive differences in NN
intervals); and pNN50 (percent of adjacent
NN intervals differing by more than 50 ms).
All three parameters mainly reﬂect the inﬂu-
ence of the parasympathetic system on the
heart, and they highly correlate with each
other. Additional time-domain parameters
(SDANN and SDNNIX) are less frequently
used, especially as their physiologic meaning
is less well understood. Figure 2 shows exam-
ples of NN interval distribution in subjects
with normal and decreased HRV. Time-
domain HRV parameters are stable over time
and show good reproducibility, which makes
them useful in clinical studies and in research
applications. SDNN, representing overall
variability of heart rate, has been shown to be
a predictor of cardiac death in various patient
populations, including patients with
myocardial infarction, nonischemic cardio-
myopathy, hypertension, diabetes, COPD,
and even in healthy subjects (12–15). 
Frequency-Domain HRV Analysis
The frequency-domain approach is based on
the power spectral analysis of the NN interval
series (tachogram) for identiﬁcation of periodic
components in the ECG signal and estimation
of their amplitude and frequency (12–14).
Respiratory modulation of the heart rate is dri-
ven by the number of breaths per minute, usu-
ally 12–15 in a healthy adult subject; the
number could be expressed as 12–15 cycles per
60 sec, i.e., 0.20–0.25 Hz. This frequency is in
the high frequency (HF) band of HRV, which
is defined between 0.15–0.40 Hz, reflecting
respiratory modulations of 9–24 breaths per
minute. The ECG signal consists of several
components apart from respiratory (vagally)
modulated HF, and frequency-domain HRV
analysis provides information about the contri-
bution of all frequencies representing oscilla-
tory patterns of heart rate. Figure 3 compares
power spectrums of heart rate in a normal
subject and in a subject with depressed HRV.
The energy (magnitude) of the overall variabil-
ity is measured for the entire spectrum, i.e.,
total power (TP) from 0 to 0.40 Hz, which is
mathematically equal to heart period variance
[SDNN]2. The energy of HRV is also mea-
sured in specific frequency bands defined as
HF (0.15–0.40 Hz), low frequency (LF;
0.04–0.15 Hz), very low frequency (VLF;
0.003–0.04 Hz), and ultra-low frequency
(ULF; < 0.003 Hz). The total power usually is
calculated as the sum of the above components
of the spectrum between 0 and 0.4 Hz, reﬂect-
ing the total HRV. As described above, the HF
represents parasympathetic (respiratory) mod-
ulation of the heart. The LF power reflects
modulation of sympathetic and parasympa-
thetic tone but with strong dominance of sym-
pathetic inﬂuence; therefore LF is considered
an indicator of sympathetic tone and barore-
ﬂex sensitivity (13). Physiologic background of
VLF and ULF is not well understood; they
account for long-term regulation mechanisms
(< 0.04 Hz, i.e., 1 cycle every 25 sec up to 1
cycle every few minutes), and they are believed
to reflect thermoregulation and possibly the
renin–angiotensin system (13). Because the
heart is affected by sympathovagal modula-
tion, the frequency-domain method provides
the opportunity to evaluate the relative contri-
bution of sympathetic and parasympathetic
tones by computing the LF/HF ratio (sympa-
thovagal tone). Frequency-domain HRV mea-
sures are less stable and less reproducible than
time-domain HRV parameters, especially if
used for analysis of short-term ECG record-
ings. There is large natural physiologic varia-
tion of frequency-domain values. In
short-term recordings, frequency-domain
analysis yields reproducible results, assuming
reproducibility of recording conditions. Time-
and frequency-domain parameters computed
from 24-hr recordings correlate well with each
other (13). Frequency-domain parameters,
including HF, LF, LF/HF ratio, VLF, and
ULF, can be used to identify patients at risk
for cardiac death (12–14).
Heart Rate Variability 
and Air Pollution
Regardless the method used to quantify HRV,
decreased HRV implies impaired autonomic
nervous activity and increased risk for cardiac
events associated with imbalance between
effects of sympathetic and parasympathetic
systems on the cardiovascular system (12–15).
Data in the literature are still limited describ-
ing the association between air pollution and
changes in HRV; nevertheless, they indicate
that in some patient populations (or in some
pathologic conditions in animal laboratories)
air pollution may contribute to altered HRV.
Pope et al. (16) measured HRV parameters
and levels of PM10 and found that elevation of
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Figure 2. Time-domain HRV analysis: distribution of NN intervals in a healthy subject (A) and in a patient with dilated
cardiomyopathy (B). Respective SDNN values are 162 msec and 63 msec, and respective rMSSD values are 34 msec
and 10 msec.
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Figure 3. Frequency-domain HRV analysis: distribution of NN intervals in a healthy subject (A) and in a patient after
myocardial infarction (B). c/b, cycles per beat. HFnu, high frequency content normalized for total power; LFnu, low fre-
quency content normalized for total power. In healthy subject, LF = 121 msec2, HF = 309 msec2, and LF/HF ratio =
0.39. In patient after myocardial infarction, LF = 893 msec2, HF = 51 msec2, and LF/HF ratio = 17.40. Zareba et al.
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PM10 was associated with increased heart rate
and decreased HRV. Although the study had
some limitations (a small number of subjects
with various diseases and medication), results
suggested that modulation of autonomic ner-
vous activity was one of the mechanisms by
which air pollution affected the cardiovascular
system (16,17). Recently, Gold et al. (17) fur-
ther conﬁrmed that changes in HRV parame-
ters were induced by air pollution in a study
of elderly residents in a Boston housing com-
munity. The authors measured daily varia-
tions of HRV parameters and levels of air
pollution and showed that increased levels of
PM2.5 correlated signiﬁcantly with decreased
HRV (17). Animal studies also indicate that
concentrated ambient particles induce HRV
changes consistent with increased sympathetic
nervous system activity (18,19). However,
questions remain about the mechanisms link-
ing inhalation of ambient particles and HRV:
Are HRV parameters changed because of air-
way-mediated reflexes from the autonomic
nervous system? Is the response of the auto-
nomic nervous system secondary to the direct
effect of particles inducing inflammatory
response? Does particle-triggered ischemia
play a role? 
Myocardial Substrate 
The pathophysiology of cardiac death indicates
the important role of changes in the
myocardium that create the substrate for
mechanisms leading to increased morbidity
and frequently to fatal cardiac events (13).
Changes in myocardial substrate are routinely
detected by evaluating hemodynamic function
of the heart (using echocardiography, radionu-
clide, or angiographic methods) and by analyz-
ing features of electrical activity in the
myocardium using electrocardiography meth-
ods. Myocardial infarction, chronic ischemic
heart disease, hypertension, and COPD may
lead to significant changes in myocardium
expressed in ECG recordings as signs of
myocardial injury, abnormal rhythm, abnor-
mal conduction, ischemia, or hypertrophy. An
ECG signal provides useful information about
the myocardial substrate (Figure 4), with P
waves representing atrial activation (depolariza-
tion), PR intervals reﬂecting atrio-ventricular
conduction of electrical signals between sinus
node and ventricular endocardium, QRS
complexes representing ventricular activation
(depolarization), and QT intervals, ST seg-
ments, and T waves describing speciﬁc aspects
of ventricular deactivation (repolarization).
ECG analysis of parameters reﬂecting myocar-
dial substrate is critical to integral evaluation of
mechanisms contributing to increased morbid-
ity and mortality (12,13). 
QRS Complex
Chronic ischemic processes, hypertension,
COPD, or even asthma may induce myocar-
dial changes affecting both ventricular depo-
larization and repolarization. Changes in the
ventricular depolarization process (frequently
caused by myocardial ﬁbrosis) can be assessed
by evaluating duration and morphology of
the QRS complex in standard and in signal-
averaged ECGs (20). Detection of QRS pro-
longation, late potentials, or fractionation of
the QRS complex may identify individuals
with increased propensities to arrhythmo-
genic response to air pollution. Although one
may speculate that air pollution could affect
myocardial depolarization, it is difficult to
imagine that changes would be large enough
to be detectable by monitoring QRS changes. 
Myocardial Ischemia (ST-Segment
Analysis)
Chronic myocardial ischemia is a silent risk
factor, creating suitable conditions for
increased vulnerability to arrhythmias and
increased risk of heart failure (21). Standard
exercise testing with ST-segment monitoring
or 24-hr Holter ST-segment monitoring may
provide insight into the magnitude of
ischemic myocardial changes. Although
1-mm ST depression is a clinically used para-
meter for detecting ischemic response, it is
possible that air pollution could induce
ischemic changes of lesser degree in patients
with ischemic heart disease. Heart rate adjust-
ment for ST-segment analysis may be of fur-
ther beneﬁt in detecting more subtle changes
in the ischemic milieu of the myocardium. 
QT Interval—Ventricular Repolarization
Ventricular repolarization is a complex
process with a proven critical role in the
arrhythmogenic response. A multitude of ion
currents operating during repolarization
makes this period vulnerable to even subtle
changes in autonomic tone, oxygenation of
myocardial cells, or electrolyte changes. The
paradigm of long QT syndrome, an inherita-
ble disorder of prolongation of ventricular
repolarization (QT interval) and a propensity
toward life-threatening ventricular arrhyth-
mias, continuously improves our under-
standing of the electrophysiology of
repolarization processes in the myocardial
cell (22,23). Duration of the QT interval,
adjusted for heart rate (QTc), is widely used
in clinical medicine to quantify baseline
repolarization abnormalities as well as to
identify changes in repolarization duration
due to additional factors such as medications.
It is possible that air pollution may alter
repolarization, leading to prolonged repolar-
ization throughout mechanisms operating
on potassium or calcium ion channels.
Heterogeneity of repolarization in the
myocardium has been found to be an impor-
tant substrate for ventricular arrhythmias
(24,25). The magnitude of repolarization
heterogeneity could be estimated by quanti-
fying T-wave morphology (for example,
using principal component analysis).
Analysis of QT dispersion is less important,
as there is no proof that this ECG parameter
reflects repolarization heterogeneity and as
QT dispersion is, to a major extent, an indi-
rect and inaccurate description of T-wave
(T-loop) morphology (26,27). Current
approaches quantifying repolarization mor-
phology seek methods independent from
T-wave end point location and that quantify
the overall shape of the repolarization seg-
ment. Subjects with underlying increased
dispersion of refractoriness, in the course of
ischemic heart disease, cardiomyopathy,
genetic predisposition (i.e., long QT syn-
drome, ion channel gene or beta-receptor gene
polymorphisms), or in the course of COPD,
could be prone to arrhythmias triggered by air
pollution. For example, Sarubbi et al. (28)
found that QTc dispersion was significantly
greater in patients with severe COPD than in
healthy subjects. It is also possible that subtle
changes in ion channel function could be trig-
gered by the indirect inﬂuence of air pollution
through autonomic changes, ischemic, or
inflammatory processes. However, to date
there has been no experimental or clinical evi-
dence for an association between air pollution
and repolarization abnormalities. 
Myocardial Vulnerability
The myocardium is under the constant inﬂu-
ence of internal and external stimuli, which
contributes to the dynamic behavior of many
of the previously described ECG parameters.
Some individuals might be more likely to
adverse outcomes because of myocardial
vulnerability that predisposes them to arrhyth-
mic or ischemic events. Myocardial vulnera-
bility could be evaluated using ECG
monitoring methods by quantifying cardiac
arrhythmias, transient ischemia, or dynamic
behavior of repolarization (12,13). Presence of
a myocardial substrate (e.g., an old myocardial
infarction) alone rarely leads to an adverse
outcome. Adverse outcomes in such postin-
farction patients usually are caused by new
occurrences of myocardial ischemia or cardiac
arrhythmias. It is conceivable that air pollu-
tion may increase myocardial vulnerability by
RR interval
QRS complex
T wave
U wave P wave
Figure 4. Schematic presentation of ECG curve with
identiﬁcation of speciﬁc waves.Air pollution and electrocardiogram
triggering cardiac arrhythmias, aggravating
myocardial ischemia, or altering the dynamics
of cardiac repolarization. Therefore, long-
term Holter ECG monitoring is likely to pro-
vide information about the effects of air
pollution on those measures of myocardial
vulnerability. Clear support for the impor-
tance of myocardial vulnerability in air pollu-
tion studies has been provided by recent
analysis of patients with implantable car-
dioverter-defibrillators, where an increase in
air pollution was associated with more
frequent arrhythmic events. Measuring fre-
quency and complexity of cardiac arrhyth-
mias in long-term ECG recording might
serve as a noninvasive parameter describing
myocardial vulnerability in air pollution
studies. Similarly, monitoring ST segments by
ECG might help identify a potential link
between air pollution and transient myocar-
dial ischemia with more ischemic episodes
present during periods of increased air pollu-
tion. Also, changes in ventricular repolariza-
tion might be also present only when
monitoring dynamic features of repolariza-
tion, such as QT adaptation to changing heart
rates, QT- and T-wave variability, or T-wave
alternans (12,13,29–31). Figure 5 illustrates
changes in repolarization dynamics presented
as a slope of the association between repolar-
ization duration and heart rate and as beat-to-
beat changes in repolarization duration.
Computerized ECG analysis of repolarization
duration and morphology may yield informa-
tion about the potential contribution of static
and dynamic repolarization abnormalities in air
pollution–related vulnerability to ventricular
arrhythmias and sudden cardiac death (12,27). 
Rochester ECG Core Lab
Experience
The above concepts of ECG monitoring for
air pollution studies are based on our ongoing
experience acquired during various cardiovas-
cular projects identifying parameters improv-
ing risk stratification in high-risk cardiac
patients. More important, these concepts are
based on our ongoing involvement in several
air pollution studies conducted by our
numerous collaborators in experimental set-
tings (rats exposed to air pollution), in clinical
studies (healthy subjects and subjects with
asthma or COPD exposed to controlled levels
of air pollution), and in epidemiologic studies
(postinfarction patients exposed to sponta-
neous environmental air pollution). This
growing experience and increasing amounts
of data will help us determine the ECG
markers most useful in identifying risk for
individuals affected by air pollution. 
Summary
In conclusion, although evidence that air pol-
lution affects the cardiovascular system is
growing, the mechanisms of such an associa-
tion are unknown. Modern electrocardiology
can offer a broad spectrum of measures that
identify the contribution of different mecha-
nistic factors to the air pollution–related
increase in cardiovascular adverse outcomes.
Comprehensive analysis of ECG parameters
describing the influence of the autonomic
nervous system, the role of the myocardial
substrate, and the contribution of myocardial
vulnerability should be conducted in air pol-
lution studies, especially because those mech-
anistic components have been proven to
contribute to increased cardiovascular mor-
bidity and mortality in general. Our recom-
mendations for ECG analysis in air pollution
studies include evaluating the following para-
meters obtained from long-term Holter
recordings: SDNN and LF/HF ratio (reﬂect-
ing the influence of the autonomic nervous
system on the heart), QT duration and T-wave
morphology (reﬂecting changes in the myocar-
dial substrate), and cardiac arrhythmias, ST-
segment, and QT dynamics analyses (reﬂecting
various aspects of myocardial vulnerability).
Current computerized ECG technology per-
mits conducting such analyses at experimental,
clinical, and epidemiologic levels.
REFERENCES AND NOTES
1. Logan WPD. Mortality in the London fog incident. Lancet
264:336–338 (1952).
2. U.S. Environmental Protection Agency. National ambient air
quality standards for particulate matter; proposed rule. Fed Reg
61(241):65638–65671 (1996).
3. National Resources Defense Council. Breath-taking. Premature
Mortality Due to Particulate Air Pollution in 239 American Cities.
Washington, DC:National Resources Defense Council, 1996;154.
4. Dockery DW, Pope CA III, Xu X, Spengler JD, Ware JH, Fay ME,
Ferris BG, Speizer FE. An association between air pollution and
mortality in six U.S. cities. N Engl J Med 329:1753–1759 (1993).
5. Miller FJ, Gardner DE, Graham JA, Lee RE Jr, Wilson WE,
Bachmann JD. Size considerations for establishing a standard
for inhalable particles. J Air Pollut Control Assoc 29:610–615
(1979).
6. Mar TF, Norris GA, Koenig JQ, Larson TV. Associations
between air pollution and mortality in Phoenix, 1995-1997.
Environ Health Perspect 108:347–353 (2000).
7. Linn WS, Szlachcic Y, Gong H Jr, Kinney PL, Berhane KT. Air
pollution and daily hospital admissions in metropolitan Los
Angeles. Environ Health Perspect 108:427–434 (2000).
8. Schwartz J. Air pollution and hospital admission for heart dis-
ease in eight U.S. counties. Epidemiology 10:17–22 (1999).
9. Knöbel HH, Chen C, Liang K. Sudden infant death syndrome in
relation to weather and optimetrically measured air pollution in
Taiwan. Pediatrics 96:1106–1110 (1995).
10. Peters A, Liu E, Verrier RL, Schwartz J, Gold DR, Mittleman M,
Baliff J, Oh JA, Allen G, Monahan K, et al. Air pollution and
incidence of cardiac arrhythmia. Epidemiology 11:11–17 (2000).
11. Watkinson WP, Campen MJ, Costa DL. Cardiac arrhythmia
induction after exposure to residual oil fly ash particles in a
rodent model of pulmonary hypertension. Toxicol Sci
41:209–216 (1998).
12. Zareba W, Locati E, Maison-Blanche P, eds. Noninvasive
Electrocardiology in Clinical Practice. Armonk, NY:Futura
Publishing Company, 2001.
13. Moss AJ, Stern S. Noninvasive Electrocardiology – Clinical
Aspects of Holter Monitoring. London:Saunders, 1995.
14. Malik M, Camm AJ. Heart Rate Variability. Armonk, New
York:Futura Publishing Company, 1995. 
15. Tsuji H, Larson MG, Venditti FJ, Manders ES, Evans JC,
Feldmann CL, Levy D. Impact of reduced heart rate variability on
risk for cardiac events. The Framingham Heart Study.
Circulation 94:2850–2855 (1996).
16. Pope CA III, Verrier RL, Lovett EG, Larson AC, Raizenne ME,
Kanner RE, Schwartz J, Villegas GM, Gold DR, Dockery DW.
Heart rate variability associated with particulate air pollution.
Am Heart J 138:890–899 (1999).
17. Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, Nearing B,
Allen G, Verrier M, Cherry R, Verrier R. Ambient pollution and
heart rate variability. Circulation 101:1267–1273 (2000).
Environmental Health Perspectives • VOLUME 109 | SUPPLEMENT 4 | August 2001 537
Figure 5. Examples of graphs illustrating dynamic behavior of repolarization measured from R-wave peak to T-wave
end (RT offset) and from R-wave peak to T-wave peak (RT apex). (A) relationship between RT offset and RR interval.
(B) Relationship between RT apex and RR interval. (C) Beat-to-beat variability of RT offset interval over time. (D) Beat-
to-beat variability of RT apex interval over time.
9:36:00 12:00:00 14:24:00 16:48:00 19:12:00 21:36:00 0:00:00 2:24:00
RT apex
Time
500
450
400
350
300
250
200
150
100
50
R
T
 
a
p
e
x
390
370
350
330
310
290
270
250
9:36 12:00:00 14:24:00 16:48:00 19:12:00 21:36:00 0:00:00 2:24:00
RT offset
Time
R
T
 
a
p
e
x
450
400
350
300
250
200
400 600 800 1,000 1,200 1,400
R
T
 
(
m
s
e
c
)
RR (msec)
RT = f(RR)
500
450
400
350
300
250
200
150
100
50
400 600 800 1,000 1,200 1,400
R
T
 
a
p
e
x
 
 
(
m
s
e
c
)
RR (msec)
RT apex = f(RR)
A
B
C
DZareba et al.
538 VOLUME 109 | SUPPLEMENT 4 | August 2001 • Environmental Health Perspectives
18. Nearing BD, Verrier RL, Skornik WA, Gazula G, Killingsworth
CR, Oakberg K, Godleski JJ. Inhaled fly ash results in cardiac
electrophysiologic function. Am J Respir Crit Care Med 153
(suppl):A543 (1996).
19. Godleski JJ, Sioutas C, Verrier RL, Killingsworth CR, Lovett E,
Krishna Murthy GG, Hatch V, Wolfson JM, Ferguson ST,
Koutrakis P. Inhalation exposure of canines to concentrated
ambient air particles. Am J Respir Crit Care Med
155(suppl):A246 (1997).
20. Hombach V, Hoher M, Osterhues HH, Kochs M. Clinical utility of
high-resolution monitoring. In: Noninvasive Electrocardiology –
Clinical Aspects of Holter Monitoring (Moss AJ, Stern S, eds).
London:Saunders, 1995;315–326. 
21. Deedwania PC. Ischemia detected by Holter monitoring in coro-
nary artery disease. In: Noninvasive Electrocardiology – Clinical
Aspects of Holter Monitoring (Moss AJ, Stern S, eds).
London:Saunders, 1995;331–344. 
22. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL,
Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, et al.
Inﬂluence of the genotype on the clinical course of the long Q
syndrome. N Engl J Med 339:960–965 (1998).
23. Chiang CE, Roden DM. The long QT syndromes: genetic basis
and clinical implications. J Am Coll Cardiol 36:1–12 (2000).
24. Kuo CS, Munakata K, Reddy CP, Surawicz B. Characteristics and
possible mechanism of ventricular arrhythmia dependent on the
dispersion of action potential durations. Circulation
67:1356–1367 (1983).
25. Yoshioka K, Gao DW, Chin M, Stillson C, Penades E, Lesh M,
O’Connell W, Dae M. Heterogeneous sympathetic innervation
inﬂluences local myocardial repolarization in normally perfuse
rabbit hearts. Circulation 101:1060–1066 (2000).
26. Zareba W. Dispersion of repolarization: time to move beyond
QT dispersion. Ann Noninvasive Electrocardiol 5:373–381
(2000).
27. Zareba W, Couderc JP, Moss AJ. Automatic detection of spatial
and temporal heterogeneity of repolarization. In: Dispersion of
Ventricular Repolarization: State of the Art (Olsson BS, Amlie
JP, Yuan S, eds). Armonk, NY:Futura, 2000;85–107. 
28. Sarubbi B, Esposito V, Ducceschi V, Meoli I, Grella E,
Santangelo L, Iacano A, Caputi M. Effect of blood gas derange-
ment on QTc dispersion in severe chronic obstructive pulmonary
disease: evidence of an electropathy? Int J Cardiol 58:287–292
(1997).
29. Burattini L, Zareba W, Rashba EJ, Couderc JP, Konecki JA,
Moss AJ. ECG features of microvolt T-wave alternans in coro-
nary artery disease and long QT syndrome patients. J
Electrocardiol 31(suppl):114–120 (1998).
30. Couderc JP, Zareba W, Burattini L, Moss AJ. Beat-to-beat repo-
larization variability in LQTS patients with the SCN5A sodium
channel gene mutation. PACE (Pacing Clin Electrophysiol)
22:1581–1592 (1999).
31. Burattini L, Zareba W. Time-domain analysis of beat-to-beat
variability of repolarization morphology in patients with ischemic
cardiomyopathy. J Electrocardiol 32(suppl):166–172 (1999).